Ultragenyx reposted this
Ryan Dant, 37, felt like his life came full circle when he started working at the Muenzer MPS Research & Treatment Center in Chapel Hill last year. As the longest-treated patient on enzyme replacement therapy for mucopolysaccharidosis type I (MPS I) in the world, he now gets to help others who have the same type of condition get the treatment they need. “It’s amazing I’m now working at a center that does both cutting-edge treatment and research,” Dant says. “When I was diagnosed at age 3, there were no centers and no specialists who had developed a treatment. It’s crazy to see how much has changed and to get to be a part of that change. I know that families are so grateful that there is a center that specializes in providing care and support for all MPS subtypes.” Patients who have MPS, a family of genetic diseases, don’t have the enzymes they need to break down large sugar molecules—which is necessary for their bodies to function. The Muenzer MPS Research & Treatment Center is dedicated to developing new treatment options for children and adults like Dant. *The graduation photo of Ryan Dant in the blue graduation gown is with Dr. Emil Kakkis, the physician/scientist who developed the missing enzyme therapy that Ryan's taken since 1998. He has been present at many of Ryan's major life milestones—high school graduation, college graduation, engagement, and wedding to name a few.